| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,367 |
1,160 |
$110K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
333 |
300 |
$41K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
788 |
692 |
$17K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
719 |
656 |
$13K |
| 80053 |
Comprehensive metabolic panel |
2,286 |
1,839 |
$11K |
| 0002A |
|
1,303 |
1,257 |
$10K |
| 0001A |
|
1,166 |
1,140 |
$10K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
288 |
260 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
768 |
672 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,468 |
1,874 |
$7K |
| 70450 |
Computed tomography, head or brain; without contrast material |
142 |
124 |
$5K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
272 |
244 |
$3K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
25 |
24 |
$2K |
| 81025 |
|
391 |
341 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
45 |
42 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
17 |
13 |
$2K |
| 81001 |
|
722 |
625 |
$967.41 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
14 |
12 |
$943.82 |
| 83690 |
|
495 |
433 |
$808.66 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
15 |
12 |
$712.30 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
106 |
102 |
$709.77 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
35 |
27 |
$700.61 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
45 |
42 |
$565.00 |
| 84484 |
|
158 |
140 |
$539.95 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
105 |
95 |
$496.08 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
84 |
73 |
$494.30 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
54 |
48 |
$225.90 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
697 |
566 |
$215.41 |
| 85610 |
|
191 |
164 |
$172.52 |
| 36415 |
Collection of venous blood by venipuncture |
2,482 |
2,062 |
$115.59 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
49 |
40 |
$109.91 |
| 81003 |
|
42 |
41 |
$44.55 |
| 85730 |
|
33 |
27 |
$29.55 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
18 |
12 |
$22.08 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
45 |
43 |
$19.28 |
| 83735 |
|
14 |
12 |
$16.61 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
71 |
40 |
$7.58 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
728 |
527 |
$1.00 |
| 82962 |
|
37 |
24 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
50 |
42 |
$0.00 |